logo-loader
Redx Pharma Plc

'It's a particularly exciting time for Redx Pharma' - Capital Network's Riccardo Lowi

Capital Network's Healthcare Analyst Riccardo Lowi gives his view on Redx Pharma Plc (LON:REDX).

''The reason it's a particularly exciting time for the company is because they're moving  their two lead candidates into the clinical stage, it's the first time they're moving a drug candidate into human trials'', Lowi says.

Quick facts: Redx Pharma Plc

Price: £0.09

Market: AIM
Market Cap: £10.75 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Redx Pharma Plc named herein, including the promotion by the Company of Redx Pharma Plc in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Capital Network analyst on MTI Wireless Edge's water management acquisition

Capital Network analyst Ed Stacey discusses MTI Wireless Edge Ltd's (LON:MWE) decision to buy a 50% stake in one of the main resellers of its Mottech Water Solution in Australia. The addition of Parkland Australia for up to AU$0.8mln is expected to enhance earnings and offer potential to...

on 06/27/2019

2 min read